Comparison of Postoperative Analgesic Effectiveness of Superficial and Deep Serratus Plane Blocks for Mastectomy
1 other identifier
interventional
63
1 country
1
Brief Summary
Pain after breast surgery can be quite severe and can significantly affect quality of life. By successfully treating acute pain, it is aimed to prevent the formation of pain memory and to ensure that chronic pain never occurs. It is known that by using regional techniques, the use of general anesthetics and opioids can be reduced and their harmful effects can be limited. In this study, it will be compared the analgesic effectiveness of superficial and deep serratus plane blocks in the postoperative acute and chronic periods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2024
CompletedFirst Posted
Study publicly available on registry
May 31, 2024
CompletedStudy Start
First participant enrolled
June 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2025
CompletedAugust 12, 2025
May 1, 2024
8 months
May 9, 2024
August 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postoperative morphine consumption
How much morphine the patient consumed in the first 24 hours postoperatively with a patient-controlled anesthesia device
24 hours
Secondary Outcomes (1)
measuring pain scors
24 hours
Study Arms (2)
Group I (superficial serratus anterior plane block)
ACTIVE COMPARATORSingle-shot ultrasound (Esaote Mylab30) guided Superficial SAP block with 30 ml 0.25% bupivacain (Marcain 0.5%, Astra Zeneca, Turkey) at the T4- T5 ribs level (between the latissimus dorsi muscle and the serratus anterior muscle) was performed preoperatively to patients in the Superficial SAP group (Group I)
Group II (deep serratus anterior plane block)
ACTIVE COMPARATORSingle- shot ultrasound (Esaote Mylab30) guided Deep SAP block with 30 ml 0.25% bupivacain (Marcain 0.5%, Astra Zeneca, Turkey) at the T4- T5 ribs level ( between the serratus anterior muscle and the ribs) was performed preoperatively to patients in the Deep SAP group (Group I)
Interventions
group I: superficial SAP Block for postoperative analgesia for mastectomy group II: deep SAP Block for postoperative analgesia for mastectomy
Eligibility Criteria
You may qualify if:
- patients who will undergo mastectomy surgery
- patients who agreed to participate in the study
- ASA I-II patients
You may not qualify if:
- Patients planned for bilateral breast surgery
- Patients who have had previous breast surgery
- Patients with existing neuropathic pain or receiving treatment for neuropathic pain
- Patients with psychiatric disorders
- Patients with opioid addiction
- Patients allergic to local anesthetics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Erciyes
Kayseri, Talas, 38100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ayşe Ülgey, MD
TC Erciyes University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor doctor
Study Record Dates
First Submitted
May 9, 2024
First Posted
May 31, 2024
Study Start
June 24, 2024
Primary Completion
February 24, 2025
Study Completion
May 25, 2025
Last Updated
August 12, 2025
Record last verified: 2024-05